Инструкция по применению PLUSFLEX
Содержание инструкции
- What is Plusflex and what is it used for
- What you need to know before using Plusflex Do not use Plusflex
- How to use Plusflex
- Possible side effects
- How to store Plusflex
- Contents of the pack and other information
Plusflex, solution for infusion
Amino acids/glucose/electrolytes
Read this leaflet carefully before you start to use this medicine as it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4. Contents of this leaflet:
- 1. What Plusflex is and what it is used for
- 2. What you need to know before you use Plusflex
- 3. How to use Plusflex
- 4. Possible side effects
- 5. How to store Plusflex
- 6. Contents of the pack and other information
1. What is Plusflex and what is it used for
The product contains nutrients called amino acids, salts (electrolytes) and glucose, which are
essential for the body for growth or healing, and calories in the form of carbohydrates.
This product is administered to you intravenously (infusion) because you are unable to eat
sufficiently or cannot be fed with a tube. Plusflex is specifically indicated for
patients in a moderately severe catabolic state, a condition in which patients burn their own
energy reserves, proteins, etc. more quickly than they can replenish them.
2. What you need to know before using Plusflex Do not use Plusflex
- if you are allergic to the active ingredients or any of the other ingredients of this medicine (listed in section 6)
- if you suffer from a congenital error of amino acid metabolism and must follow a specific protein diet
- if you have blood glucose levels that are too high and require more than 6 units of insulin per hour to keep them under control
- if you have excessively high levels of acidic substances in the blood (acidosis)
- if you have bleeding in the brain or spinal cord
- if you suffer from severe liver failure (severe hepatic insufficiency)
- if you suffer from severe kidney failure (severe renal insufficiency) without resorting to treatment with an artificial kidney (hemofiltration or dialysis)
- Like other medicines of the same type, Plusflex should not be administered in case of: acute heart attack (myocardial infarction) or stroke
- any poorly controlled metabolic disorder, such as unconsciousness (coma) of unknown origin or insufficient oxygen supply to the tissues or uncontrolled diabetes mellitus
- potentially fatal circulatory disorders, such as those that can occur, for example, in the event of collapse or shock, fluid accumulation in the lungs (pulmonary edema) or disturbances of fluid balance
Plusflex should not be administered to newborns, infants and children under two years of age.
Warnings and precautions
- if you have impaired heart or kidney function;
- if you have disturbances of fluid or electrolyte balance or acid-base balance, for example, a low content of fluids and salts in the body (hypotonic dehydration) or low levels of sodium or potassium in the blood;
- if you have blood sugar levels that are too high. Your daily dose will be established and monitored with particular caution in case of disorders of kidney, liver, adrenal gland, heart or lung function. The doctor will also use particular caution in case of damage to the blood-brain barrier, because this medicine may cause an increase in pressure inside the skull or spinal cord.
If you are in a state of severe malnutrition, intravenous nutrition will be carried out gradually with
particular caution, with adequate monitoring and with the necessary supply of electrolytes, in particular potassium,
magnesium and phosphate.
This medicine contains glucose (a sugar) and may therefore affect blood glucose levels. It is possible
that blood samples may need to be taken to verify this eventuality.
If the infusion is suddenly interrupted accidentally, blood glucose levels may also drop
sharply. The doctor will take this into account particularly if your ability to metabolize
glucose is reduced (for example, if you suffer from diabetes) or when the solution is administered to children
under 3 years of age.
Therefore, blood glucose must be carefully monitored especially after the infusion is stopped.
In addition, blood salt levels, fluid balance, acid-base balance and blood cell count, coagulation and kidney and liver function need to be monitored.
The doctor will ensure that your fluid and electrolyte needs are met. In addition to Plusflex,
you will receive other nutrients (food) to fully meet your needs.
As with all intravenous solutions, strict aseptic precautions must be observed for the infusion of Plusflex.
Children and adolescents
In the event of a sudden drop in your child's blood glucose following the sudden interruption
of the infusion, also refer to the previous paragraph “Warnings and precautions”.
The doctor will not administer Plusflex to children under two years of age.
Other medicines and Plusflex
Tell your doctor if you are taking, have recently taken or might take any other
medicines.
Plusflex can interact with other medicines. Tell your doctor if you are taking any of the following
medicines:
- medicines used for the treatment of inflammation (corticosteroids);
- hormonal preparations that affect fluid balance (adrenocorticotropic hormone [ACTH]);
- medicines that promote urine flow (diuretics), such as spironolactone, triamterene or amiloride;
- medicines for the treatment of high blood pressure (ACE inhibitors), such as captopril and enalapril
- medicines used for the treatment of high blood pressure or heart problems (angiotensin II receptor antagonists), such as losartan and valsartan
- medicines used in organ transplantation, such as cyclosporine and tacrolimus. Pregnancy, breastfeeding and fertilityIf you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
If you are pregnant, you will only receive this medicine if your doctor deems it absolutely
necessary for your recovery.
Breastfeeding
Breastfeeding is not recommended if the woman needs intravenous nutrition.
Fertility
No data are available.
Driving and operating machinery
This medicine is usually administered to immobilized patients, for example in hospital or clinic.
This condition excludes driving and operating machinery. However, the medicine itself does not
alter the ability to drive or operate machinery.
3. How to use Plusflex
This medicine will be administered to you by intravenous infusion (drip), i.e. through a small cannula inserted directly into a large vein.
The solution must always be brought to room temperature before infusion.
The doctor will determine the amount of medicine you need and the duration of treatment.
The recommended daily dose for adults is up to 40 mL of infusion solution per kg of body weight.
The doctor will determine the exact dose.
Use in children and adolescents
There are special dosage criteria for children and adolescents aged between 2 and 17 years. The doctor
will determine the dose based on these criteria.
If you have received more Plusflex than you should
With correct administration, it is unlikely that you will receive an excessive dose of this medicine.
However, if you receive an excessive amount, the following effects may occur:
- too high levels of body fluids (hyperhydration)
- excessively high amount of urine (polyuria)
- disorders of salt composition in the body (electrolyte imbalances)
- water in the lungs (pulmonary edema)
- loss of amino acids in the urine and disorders of amino acid balance
- accumulation of acidic substances in the blood (metabolic acidosis)
- discomfort, vomiting, chills, headache
- high levels of nitrogen in the blood (hyperammonemia)
- too high blood glucose levels (hyperglycemia)
- glucose in the urine (glycosuria)
- lack of fluids (dehydration)
- blood concentration much higher than normal (hyperosmolality)
- state of unconsciousness due to extremely high blood sugar (hyperglycemic-hyperosmolar coma). If any of these symptoms occur, the infusion will be stopped immediately. The doctor will determine the additional treatment you need to receive. The infusion will not be resumed until your condition has improved. If you have any doubts about the use of this medicine, ask your healthcare professional.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects are mainly due to an overdose or too rapid an infusion, and generally
disappear at the end of the infusion.
Rare (may affect up to 1 in 1,000).
- Discomfort (Nausea), vomiting and decreased appetite.
If these side effects occur, treatment should be discontinued, or the doctor may decide
to continue it at lower doses.
Reporting of side effects
If any of these side effects gets worse, or if you notice any side effects,
including those not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly
through the national reporting system at
www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects you can help provide more information on the safety of this
medicine.
5. How to store Plusflex
Keep this medicine out of the sight and reach of children.
Do not store at a temperature above 25°C.
Keep the bag in the outer packaging to protect the medicine from light.
Do not use this medicine after the expiry date which is stated on the label.
. The expiry date refers to the last day of the month.
6. Contents of the pack and other information
What Plusflex contains
- The active ingredients are amino acids, glucose and electrolytes. After mixing, each bag contains:
|
| |
| g Isoleucine | 2.82 g | 5.64 g |
| Leucine | 3.76 g | 7.52 g |
| A Lysine hydrochloride equivalent to lysine | 3.41 g 2.73 g | 6.82 g 5.46 g |
| Methionine | 2.35 g | 4.70 g |
| Phenylalanine | 4.21 g | 8.42 g |
- Other ingredients are citric acid monohydrate and water for injections.
| Threonine | 2.18 g | 4.36 g |
| Tryptophan | 0.68 g | 1.36 g |
| Valine | 3.12 g | 6.24 g |
| Arginine monoglutamate equivalent to arginine equivalent to glutamic acid | 5.98 g 3.24 g 2.74 g | 11.96 g 6.48 g 5.48 g |
| Histidine hydrochloride monohydrate equivalent to histidine | 2.03 g 1.50 g | 4.06 g 3.00 g |
| Alanine | 5.82 g | 11.64 g |
| Aspartic acid | 1.80 g | 3.60 g |
| Glutamic acid | 1.47 g | 2.94 g |
| Glycine | 1.98 g | a 3.96 g |
| Proline | 4.08 g | 8.16 g |
| Serine | 3.60 g | F 7.20 g |
| Magnesium acetate tetrahydrate | 1.23 g | 2.46 g |
| Sodium acetate trihydrate | 1.56 g | 3.12 g |
| Sodium dihydrogen phosphate dihydrate | 3.12 g | l 6.24 g |
| Potassium hydroxide | 1.40 g | e 2.80 g |
| Sodium hydroxide | 0.23 g | 0.46 g |
| Glucose monohydrate equivalent to glucose | 165.0 g 150.0 g | d 330.0 g 300.0 g |
| Calcium chloride dihydrate | 0.53 g | 1.06 g |
| Electrolytes | a
|
|
| Sodium | 37.2 mmol | 74.4 mmol |
| Potassium | i 25.0 mmol | 50.0 mmol |
| Calcium | l 3.6 mmol | 7.2 mmol |
| a Magnesium | 5.7 mmol | 11.4 mmol |
| Chloride | 35.5 mmol | 71.0 mmol |
| t Phosphate | 20.0 mmol | 40.0 mmol |
| I Acetate | 22.9 mmol | 45.8 mmol |
| a |
|
|
| i Amino acid content | 48 g | 96 g |
| Nitrogen content | 6.8 g | 13.6 g |
| z Carbohydrate content | 150 g | 300 g |
| n |
|
|
| e Energy supply in the form of amino acids [kJ (kcal)] | 803 (192) |
|
| g Energy supply in the form of carbohy- drates [kJ (kcal)] |
|
|
| Total energy supply [kJ (kcal)] |
|
|
| A Theoretical osmolarity [mOsm/L] |
|
|
| pH | 4.8 – 6.0 | 4.8 – 6.0 |
Description of the appearance of Plusflex and contents of the pack
This medicine is a solution for infusion to be administered directly into a vein through a
small cannula.
Plusflex is supplied in a two-compartment infusion bag. The lower compartment contains
glucose, while the upper compartment contains the amino acid solution. The glucose and
amino acid solutions are clear, colorless or slightly straw-colored.
The product is supplied in plastic two-compartment bags containing:
- 1.000 ml (400 ml of amino acid solution + 600 ml of glucose solution)
- 2.000 ml (800 ml of amino acid solution + 1.200 ml of glucose solution) Pack sizes: 5×1.000 ml, 5×2.000 ml Not all pack sizes may be marketed. Marketing authorisation holder and manufacturer
- B. Braun Melsungen AG Carl-Braun-Straße 1 Postal address 34212 Melsungen, Germany 34209 Melsungen, Germany Tel.: +49-5661-71-0 Fax: +49-5661-71-4567
-------------------------------------------------------------------------------------------------------------------------
The following information is intended exclusively for doctors or healthcare professionals:
The solution must always be brought to room temperature before infusion.
Use Plusflex only if the solution is clear and the bag is intact. After the infusion, any remaining solution must never be stored for future use.
Preparation of the mixture
Immediately before use, the internal septum separating the two compartments must be opened, to
allow aseptic mixing of the components.
Remove the bag from the protective bag and proceed as follows:
- Lay the bag flat and place it on a rigid surface.
- Open the septum by pressing with both hands.
- Briefly mix the contents of the bag. An additional connector allows the addition of supplements to Plusflex. Strict aseptic precautions must be observed when adding other solutions or lipid emulsions to Plusflex. Lipid emulsions can be easily added with a specific transfer set.
Maximum infusion rate
The maximum infusion rate for adults, children and adolescents between 2 and 17 years of age is
1.6 mL per kg of body weight per hour.
Storage after mixing the contents
Plusflex should be administered preferably immediately after mixing the two solutions, but if immediate
administration is not possible, under certain circumstances it can be stored for a
maximum of 7 days at room temperature and for a maximum of 14 days in a refrigerator at 2 - 8 °C
(including the time of administration). Partially used containers must not be
stored for future use.

- Страна регистрации
- Форма выпускаInfusion solution, 1000 ML
- Код АТХB05BA10
- Действующее вещество
- Отпускается по рецептуДа
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги PLUSFLEXФорма выпуска: Infusion solution, 10%Действующее вещество: combinationsПроизводитель: B. BRAUN MELSUNGEN AGОтпускается по рецептуФорма выпуска: Infusion solution, 1000 MLДействующее вещество: combinationsПроизводитель: B. BRAUN MELSUNGEN AGОтпускается по рецептуФорма выпуска: Infusion solution, 1000 MLДействующее вещество: combinationsПроизводитель: BAXTER S.P.A.Отпускается по рецепту
Аналоги PLUSFLEX в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог PLUSFLEX в Испания
Аналог PLUSFLEX в Польша
Аналог PLUSFLEX в Украина
Врачи онлайн по PLUSFLEX
Обсудите применение PLUSFLEX и возможные следующие шаги — по оценке врача.
Получите рецепт на PLUSFLEX онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
PLUSFLEX требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
Действующее вещество PLUSFLEX — combinations. Эта информация помогает определить лекарства с тем же составом под другими торговыми названиями.
PLUSFLEX производится компанией B. BRAUN MELSUNGEN AG. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения PLUSFLEX с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить PLUSFLEX в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом (combinations) включают AMIXAL, BASALFLEX, KLINIMIX. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















